Funded Pilot and Feasibility Study #2:Title: Glycosaminoglycan reactivity in lupus as a predictor of diseasePI: Fei Shih, M.D., Ph.D.A.
Specific Aims Systemic lupus erythematosus (SLE) is characterized by the production of autoantibodies andautoimmune attack of multiple organs. We hypothesized that there are novel targets yet to bediscovered for SLE and these may serve as predictors of disease. Based on the highly patternedstructure of DNA, we hypothesized that cross reactivity to glycosaminoglycans (GAGs), also a highlypatterned structure, may serve as a biomarker for various disease manifestations. This pilot studyexamines aGAG reactivity in a murine model of SLE and extends aGAG analysis to pediatricpatients with SLE with the following specific aims: 1) An unbiased examination of aGAG antibodiesin KRN/G7m mice, a murine model of SLE; and 2) Characterize aGAG antibodies in SLE patientsand correlation with disease.
Showing the most recent 10 out of 156 publications